TY - JOUR AU - Dranitsaris, G. AU - Truter, I. AU - Lubbe, M. S. AU - Amir, E. AU - Evans, W. PY - 2011 DA - 2011// TI - Advances in cancer therapeutics and patient access to new drugs JO - Pharmacoeconomics VL - 29 UR - https://doi.org/10.2165/11584210-000000000-00000 DO - 10.2165/11584210-000000000-00000 ID - Dranitsaris2011 ER - TY - JOUR AU - Schoenlein, P. V. AU - Hou, M. AU - Samaddar, J. S. PY - 2007 DA - 2007// TI - Downregulation of retinoblastoma protein is involved in the enhanced cytotoxicity of 4-hydroxytamoxifen plus mifepristone combination therapy versus antiestrogen monotherapy of human breast cancer JO - Int J Oncol VL - 31 ID - Schoenlein2007 ER - TY - JOUR AU - Hou, N. AU - Huo, D. PY - 2013 DA - 2013// TI - A trend analysis of breast cancer incidence rates in the United States from 2000 to 2009 shows a recent increase JO - Breast Cancer Res Treat VL - 138 UR - https://doi.org/10.1007/s10549-013-2434-0 DO - 10.1007/s10549-013-2434-0 ID - Hou2013 ER - TY - JOUR AU - Horowitz, N. S. AU - Miller, A. AU - Rungruang, B. PY - 2015 DA - 2015// TI - Does aggressive surgery improve outcomes? Interaction between preoperative disease burden and complex surgery in patients with advanced-stage ovarian cancer: an analysis of GOG 182 JO - J Clin Oncol VL - 33 UR - https://doi.org/10.1200/JCO.2014.56.3106 DO - 10.1200/JCO.2014.56.3106 ID - Horowitz2015 ER - TY - JOUR AU - Lippman, M. E. AU - Krueger, K. A. AU - Eckert, S. PY - 2001 DA - 2001// TI - Indicators of lifetime estrogen exposure: effect on breast cancer incidence and interaction with raloxifene therapy in the multiple outcomes of raloxifene evaluation study participants JO - J Clin Oncol VL - 19 UR - https://doi.org/10.1200/JCO.2001.19.12.3111 DO - 10.1200/JCO.2001.19.12.3111 ID - Lippman2001 ER - TY - JOUR AU - Wodarz, D. AU - Zauber, A. G. PY - 2015 DA - 2015// TI - Cancer: Risk factors and random chances JO - Nature VL - 517 UR - https://doi.org/10.1038/517563a DO - 10.1038/517563a ID - Wodarz2015 ER - TY - JOUR AU - Fedewa, S. A. AU - Sauer, A. G. AU - Siegel, R. L. AU - Jemal, A. PY - 2015 DA - 2015// TI - Prevalence of Major Risk Factors and Use of Screening Tests for Cancer in the United States JO - Cancer Epidemiol Biomarkers Prev VL - 24 UR - https://doi.org/10.1158/1055-9965.EPI-15-0134 DO - 10.1158/1055-9965.EPI-15-0134 ID - Fedewa2015 ER - TY - JOUR AU - Perdue, D. G. AU - Haverkamp, D. AU - Perkins, C. AU - Daley, C. M. AU - Provost, E. PY - 2014 DA - 2014// TI - Geographic variation in colorectal cancer incidence and mortality, age of onset, and stage at diagnosis among American Indian and Alaska Native people, 1990-2009 JO - Am J Public Health VL - 104 UR - https://doi.org/10.2105/AJPH.2013.301654 DO - 10.2105/AJPH.2013.301654 ID - Perdue2014 ER - TY - JOUR AU - Steliarova-Foucher, E. AU - Stiller, C. AU - Kaatsch, P. PY - 2004 DA - 2004// TI - Geographical patterns and time trends of cancer incidence and survival among children and adolescents in Europe since the 1970s (the ACCISproject): an epidemiological study JO - Lancet VL - 364 UR - https://doi.org/10.1016/S0140-6736(04)17550-8 DO - 10.1016/S0140-6736(04)17550-8 ID - Steliarova-Foucher2004 ER - TY - JOUR AU - Ess, S. AU - Savidan, A. AU - Frick, H. PY - 2010 DA - 2010// TI - Geographic variation in breast cancer care in Switzerland JO - Cancer Epidemiol VL - 34 UR - https://doi.org/10.1016/j.canep.2010.01.008 DO - 10.1016/j.canep.2010.01.008 ID - Ess2010 ER - TY - JOUR AU - Christian, W. J. AU - Huang, B. AU - Rinehart, J. AU - Hopenhayn, C. PY - 2011 DA - 2011// TI - Exploring geographic variation in lung cancer incidence in Kentucky using a spatial scan statistic: elevated risk in the Appalachian coal-mining region JO - Public Health Rep VL - 126 UR - https://doi.org/10.1177/003335491112600604 DO - 10.1177/003335491112600604 ID - Christian2011 ER - TY - JOUR AU - Lai, S. M. AU - Zhang, K. B. AU - Uhler, R. J. AU - Harrison, J. N. AU - Clutter, G. G. AU - Williams, M. A. PY - 2006 DA - 2006// TI - Geographic variation in the incidence of colorectal cancer in the United States, 1998-2001 JO - Cancer VL - 107 UR - https://doi.org/10.1002/cncr.22014 DO - 10.1002/cncr.22014 ID - Lai2006 ER - TY - JOUR AU - Chiou, S. T. AU - Lu, T. H. PY - 2014 DA - 2014// TI - Changes in geographic variation in the uptake of cervical cancer screening in Taiwan: possible effects of "leadership style factor"? JO - Health Policy VL - 114 UR - https://doi.org/10.1016/j.healthpol.2013.06.008 DO - 10.1016/j.healthpol.2013.06.008 ID - Chiou2014 ER - TY - JOUR AU - Smieliauskas, F. AU - MacMahon, H. AU - Salgia, R. AU - Shih, Y. C. PY - 2014 DA - 2014// TI - Geographic variation in radiologist capacity and widespread implementation of lung cancer CT screening JO - J Med Screen VL - 21 UR - https://doi.org/10.1177/0969141314548055 DO - 10.1177/0969141314548055 ID - Smieliauskas2014 ER - TY - JOUR AU - Lu, S. N. AU - Su, W. W. AU - Yang, S. S. PY - 2006 DA - 2006// TI - Secular trends and geographic variations of hepatitis B virus and hepatitis C virus-associated hepatocellular carcinoma in Taiwan JO - Int J Cancer VL - 119 UR - https://doi.org/10.1002/ijc.22045 DO - 10.1002/ijc.22045 ID - Lu2006 ER - TY - JOUR AU - McWilliams, J. M. AU - Dalton, J. B. AU - Landrum, M. B. AU - Frakt, A. B. AU - Pizer, S. D. AU - Keating, N. L. PY - 2014 DA - 2014// TI - Geographic variation in cancer-related imaging: Veterans Affairs health care system versus Medicare JO - Ann Intern Med VL - 161 UR - https://doi.org/10.7326/M14-0650 DO - 10.7326/M14-0650 ID - McWilliams2014 ER - TY - JOUR AU - Su, W. W. AU - Chen, C. H. AU - Lin, H. H. PY - 2009 DA - 2009// TI - Geographic variations of predominantly hepatitis C virus associated male hepatocellular carcinoma townships in Taiwan: identification of potential high HCV endemic areas JO - Hepatol Int VL - 3 UR - https://doi.org/10.1007/s12072-009-9146-x DO - 10.1007/s12072-009-9146-x ID - Su2009 ER - TY - JOUR AU - Guadagnolo, B. A. AU - Liu, C. C. AU - Cormier, J. N. AU - Du, X. L. PY - 2010 DA - 2010// TI - Evaluation of trends in the use of intensity-modulated radiotherapy for head and neck cancer from 2000 through 2005: socioeconomic disparity and geographic variation in a large population-based cohort JO - Cancer VL - 116 UR - https://doi.org/10.1002/cncr.25205 DO - 10.1002/cncr.25205 ID - Guadagnolo2010 ER - TY - JOUR AU - Cary, K. C. AU - Punnen, S. AU - Odisho, A. Y. AU - Litwin, M. S. AU - Saigal, C. S. AU - Cooperberg, M. R. PY - 2015 DA - 2015// TI - Nationally representative trends and geographic variation in treatment of localized prostate cancer: the Urologic Diseases in America project JO - Prostate Cancer Prostatic Dis VL - 18 UR - https://doi.org/10.1038/pcan.2015.3 DO - 10.1038/pcan.2015.3 ID - Cary2015 ER - TY - JOUR AU - Deleyiannis, F. W. AU - Weymuller, E. A. AU - Garcia, I. AU - Potosky, A. L. PY - 1997 DA - 1997// TI - Geographic variation in the utilization of esophagoscopy and bronchoscopy in head and neck cancer JO - Arch Otolaryngol Head Neck Surg VL - 123 UR - https://doi.org/10.1001/archotol.1997.01900110057008 DO - 10.1001/archotol.1997.01900110057008 ID - Deleyiannis1997 ER - TY - JOUR AU - Reames, B. N. AU - Sheetz, K. H. AU - Waits, S. A. AU - Dimick, J. B. AU - Regenbogen, S. E. PY - 2014 DA - 2014// TI - Geographic variation in use of laparoscopic colectomy for colon cancer JO - J Clin Oncol VL - 32 UR - https://doi.org/10.1200/JCO.2014.57.1588 DO - 10.1200/JCO.2014.57.1588 ID - Reames2014 ER - TY - JOUR AU - Chen, C. H. AU - Su, W. W. AU - Yang, S. S. PY - 2006 DA - 2006// TI - Long-term trends and geographic variations in the survival of patients with hepatocellular carcinoma: analysis of 11,312 patients in Taiwan JO - J Gastroenterol Hepatol VL - 21 UR - https://doi.org/10.1111/j.1440-1746.2006.04425.x DO - 10.1111/j.1440-1746.2006.04425.x ID - Chen2006 ER - TY - JOUR AU - Andia, M. E. AU - Hsing, A. W. AU - Andreotti, G. AU - Ferreccio, C. PY - 2008 DA - 2008// TI - Geographic variation of gallbladder cancer mortality and risk factors in Chile: a population-based ecologic study JO - Int J Cancer VL - 123 UR - https://doi.org/10.1002/ijc.23662 DO - 10.1002/ijc.23662 ID - Andia2008 ER - TY - JOUR AU - Kohne, C. H. AU - Lenz, H. J. PY - 2009 DA - 2009// TI - Chemotherapy with targeted agents for the treatment of metastatic colorectal cancer JO - Oncologist VL - 14 UR - https://doi.org/10.1634/theoncologist.2008-0202 DO - 10.1634/theoncologist.2008-0202 ID - Kohne2009 ER - TY - JOUR AU - Mahalingam, D. AU - Mita, A. AU - Mita, M. M. AU - Nawrocki, S. T. AU - Giles, F. J. PY - 2009 DA - 2009// TI - Targeted therapy for advanced non-small cell lung cancers: historical perspective, current practices, and future development JO - Curr Probl Cancer VL - 33 UR - https://doi.org/10.1016/j.currproblcancer.2009.03.001 DO - 10.1016/j.currproblcancer.2009.03.001 ID - Mahalingam2009 ER - TY - JOUR AU - Mok, T. S. AU - Wu, Y. L. AU - Thongprasert, S. PY - 2009 DA - 2009// TI - Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma JO - N Engl J Med VL - 361 UR - https://doi.org/10.1056/NEJMoa0810699 DO - 10.1056/NEJMoa0810699 ID - Mok2009 ER - TY - JOUR AU - Burotto, M. AU - Manasanch, E. E. AU - Wilkerson, J. AU - Fojo, T. PY - 2015 DA - 2015// TI - Gefitinib and erlotinib in metastatic non-small cell lung cancer: a meta-analysis of toxicity and efficacy of randomized clinical trials JO - Oncologist VL - 20 UR - https://doi.org/10.1634/theoncologist.2014-0154 DO - 10.1634/theoncologist.2014-0154 ID - Burotto2015 ER - TY - JOUR AU - Biswas, B. PY - 2015 DA - 2015// TI - Erlotinib versus docetaxel as second- or third-line therapy in patients with advanced non-small-cell lung cancer in the era of personalized medicine JO - J Clin Oncol VL - 33 UR - https://doi.org/10.1200/JCO.2014.57.5621 DO - 10.1200/JCO.2014.57.5621 ID - Biswas2015 ER - TY - JOUR AU - Song, Z. AU - Zhang, Y. PY - 2015 DA - 2015// TI - Efficacy of gefitinib or erlotinib in patients with squamous cell lung cancer JO - Arch Med Sci VL - 11 UR - https://doi.org/10.5114/aoms.2013.39234 DO - 10.5114/aoms.2013.39234 ID - Song2015 ER - TY - JOUR AU - Lu, C. Y. AU - Srasuebkul, P. AU - Drew, A. K. AU - Chen, K. AU - Ward, R. L. AU - Pearson, S. A. PY - 2013 DA - 2013// TI - Trastuzumab therapy in Australia: which patients with HER2+ metastatic breast cancer are assessed for cardiac function? JO - Breast VL - 22 UR - https://doi.org/10.1016/j.breast.2013.04.011 DO - 10.1016/j.breast.2013.04.011 ID - Lu2013 ER - TY - JOUR AU - Lu, C. Y. AU - Srasuebkul, P. AU - Drew, A. K. AU - Ward, R. L. AU - Pearson, S. A. PY - 2012 DA - 2012// TI - Positive spillover effects of prescribing requirements: increased cardiac testing in patients treated with trastuzumab for HER2+ metastatic breast cancer JO - Intern Med J VL - 42 UR - https://doi.org/10.1111/j.1445-5994.2011.02604.x DO - 10.1111/j.1445-5994.2011.02604.x ID - Lu2012 ER - TY - JOUR AU - Hsu, J. C. AU - Lu, C. Y. PY - 2015 DA - 2015// TI - The evolution of Taiwan's National Health Insurance drug reimbursement scheme JO - Daru VL - 23 UR - https://doi.org/10.1186/s40199-014-0080-7 DO - 10.1186/s40199-014-0080-7 ID - Hsu2015 ER - TY - JOUR AU - Hsu, J. C. AU - Lu, C. Y. PY - 2016 DA - 2016// TI - Longitudinal trends in use and costs of targeted therapies for common cancers in Taiwan: a retrospective observational study JO - BMJ Open VL - 6 UR - https://doi.org/10.1136/bmjopen-2016-011322 DO - 10.1136/bmjopen-2016-011322 ID - Hsu2016 ER - TY - JOUR AU - Hsu, J. C. AU - Gonzalez-Gonzalez, L. A. AU - Lu, V. H. AU - Lu, C. Y. PY - 2016 DA - 2016// TI - Longitudinal trends in use of targeted therapies for treatment of malignant neoplasms of the eye: a population-based study in Taiwan JO - BMJ Open VL - 6 UR - https://doi.org/10.1136/bmjopen-2015-010706 DO - 10.1136/bmjopen-2015-010706 ID - Hsu2016 ER - TY - JOUR AU - Liu, S. Z. AU - Romeis, J. C. PY - 2003 DA - 2003// TI - Assessing the effect of Taiwan's outpatient prescription drug copayment policy in the elderly JO - Med Care VL - 41 UR - https://doi.org/10.1097/01.MLR.0000100579.91550.C4 DO - 10.1097/01.MLR.0000100579.91550.C4 ID - Liu2003 ER - TY - STD TI - Hsu JC, Lu CY, Wagner AK, Chan KA, Lai MS, Ross-Degnan D. Impacts of drug reimbursement reductions on utilization and expenditures of oral antidiabetic medications in Taiwan: An interrupted time series study. Health Policy. 2013; ID - ref36 ER - TY - JOUR AU - Hsu, J. C. AU - Ross-Degnan, D. AU - Wagner, A. K. PY - 2015 DA - 2015// TI - Utilization of oral antidiabetic medications in Taiwan following strategies to promote access to medicines for chronic diseases in community pharmacies JO - J Pharm Policy Pract VL - 8 UR - https://doi.org/10.1186/s40545-015-0035-5 DO - 10.1186/s40545-015-0035-5 ID - Hsu2015 ER - TY - STD TI - Department of Statistics, Taiwan Ministry of Interior, website: http://www.ris.gov.tw/zh_TW/346. Accessed 28 July 2017. UR - http://www.ris.gov.tw/zh_TW/346 ID - ref38 ER - TY - STD TI - Report CRA. Taiwan. Health Promotion Administration. Ministry of Health and Welfare. 2011;2014 ID - ref39 ER - TY - STD TI - Mills TC. Time Series Techniques for Economists. Cambridge University Press. 1990; ID - ref40 ER - TY - STD TI - Asteriou DH, Stephen G. ARIMA Models and the Box–Jenkins Methodology, Applied Econometrics (Second ed.) Palgrave MacMillan 2011:265-86. ID - ref41 ER - TY - JOUR AU - Domenighetti, G. AU - Casabianca, A. PY - 1995 DA - 1995// TI - Health care economics, uncertainty and physician-induced demand JO - Schweiz Med Wochenschr VL - 125 ID - Domenighetti1995 ER - TY - JOUR AU - Mullins, R. J. AU - Clark, S. AU - Camargo, C. A. PY - 2010 DA - 2010// TI - Regional variation in infant hypoallergenic formula prescriptions in Australia JO - Pediatr Allergy Immunol VL - 21 UR - https://doi.org/10.1111/j.1399-3038.2009.00962.x DO - 10.1111/j.1399-3038.2009.00962.x ID - Mullins2010 ER - TY - JOUR AU - Kreng, V. B. AU - Yang, C. T. PY - 2011 DA - 2011// TI - The equality of resource allocation in health care under the National Health Insurance System in Taiwan JO - Health Policy VL - 100 UR - https://doi.org/10.1016/j.healthpol.2010.08.003 DO - 10.1016/j.healthpol.2010.08.003 ID - Kreng2011 ER - TY - JOUR AU - O'Dowd, A. PY - 2008 DA - 2008// TI - Watchdog set to reject four drugs for kidney cancer on the NHS JO - BMJ VL - 337 UR - https://doi.org/10.1136/bmj.a1262 DO - 10.1136/bmj.a1262 ID - O'Dowd2008 ER - TY - JOUR AU - Wahlstera, P. AU - Scahillb, S. AU - Lu, C. Y. AU - Babar, Z. -. U. -. D. PY - 2015 DA - 2015// TI - Barriers to access and use of high cost medicines: A review JO - Health Policy and Technology VL - 4 UR - https://doi.org/10.1016/j.hlpt.2015.04.009 DO - 10.1016/j.hlpt.2015.04.009 ID - Wahlstera2015 ER - TY - JOUR AU - Kantarjian, H. M. AU - Fojo, T. AU - Mathisen, M. AU - Zwelling, L. A. PY - 2013 DA - 2013// TI - Cancer drugs in the United States: Justum Pretium--the just price JO - J Clin Oncol VL - 31 UR - https://doi.org/10.1200/JCO.2013.49.1845 DO - 10.1200/JCO.2013.49.1845 ID - Kantarjian2013 ER - TY - JOUR AU - Lu, C. Y. AU - Williams, K. AU - Day, R. AU - March, L. AU - Sansom, L. AU - Bertouch, J. PY - 2004 DA - 2004// TI - Access to high cost drugs in Australia JO - BMJ VL - 329 UR - https://doi.org/10.1136/bmj.329.7463.415 DO - 10.1136/bmj.329.7463.415 ID - Lu2004 ER - TY - JOUR AU - Hall, W. D. AU - Ward, R. AU - Liauw, W. S. AU - Lu, C. Y. AU - Brien, J. A. PY - 2005 DA - 2005// TI - Tailoring access to high cost, genetically targeted drugs JO - Med J Aust VL - 182 ID - Hall2005 ER - TY - JOUR AU - Godman, B. AU - Malmstrom, R. E. AU - Diogene, E. PY - 2015 DA - 2015// TI - Are new models needed to optimize the utilization of new medicines to sustain healthcare systems? JO - Expert Rev Clin Pharmacol VL - 8 UR - https://doi.org/10.1586/17512433.2015.990380 DO - 10.1586/17512433.2015.990380 ID - Godman2015 ER - TY - STD TI - WHO website: http://www.who.int/mediacentre/factsheets/fs297/en/. Accessed 28 July 2017. UR - http://www.who.int/mediacentre/factsheets/fs297/en/ ID - ref51 ER -